The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25
Open accessAbstract
The calcitonin/CGRP family of peptides includes calcitonin, α and β CGRP, amylin, adrenomedullin (AM) and adrenomedullin 2/intermedin (AM2/IMD). Their receptors consist of one of two GPCRs, the calcitonin receptor (CTR) or the calcitonin receptor‐like receptor (CLR). Further diversity arises from heterodimerization of these GPCRs with one of three receptor activity‐modifying proteins (RAMPs). This gives the CGRP receptor (CLR/RAMP1), the AM 1 and AM 2 receptors (CLR/RAMP2 or RAMP3) and the AMY 1,AMY 2 and AMY 3 receptors (CTR/RAMPs1–3 complexes, respectively). Apart from the CGRP receptor, there are only peptide antagonists widely available for these receptors, and these have limited selectivity, thus defining the function of each receptor in vivo remains challenging. Further challenges arise from the probable co‐expression of CTR with the CTR/RAMP complexes and species‐dependent splice variants of the CTR (CT(a)and CT(b)). Furthermore, the AMY 1(a)receptor is activated equally well by both amylin and CGRP, and the preferred receptor for AM2/IMD has been unclear. However, there are clear therapeutic rationales for developing agents against the various receptors for these peptides. For example, many agents targeting the CGRP system are in clinical trials, and pramlintide, an amylin analogue, is an approved therapy for insulin‐requiring diabetes. This review provides an update on the pharmacology of the calcitonin family of peptides by members of the corresponding subcommittee of the International Union of Basic and Clinical Pharmacology and colleagues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134
Calcitonin Gene-Related Peptide: Physiology and Pathophysiology
Russell, F. A., King, R., Smillie, S.-J., Kodji, X., & Brain, S. D. (2014) · Physiological Reviews · doi:10.1152/physrev.00034.2013 · Cited by 1,258
Southan, C., Sharman, J. L., Benson, H. E., Faccenda, E., Pawson, A. J., Alexander, S. P. H., Buneman, O. P., Davenport, A. P., McGrath, J. C., Peters, J. A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1037 · Cited by 1,035
Poyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A., & Foord, S. M. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.233 · Cited by 804 · cited 3×
“As their names suggest, these respond to amylin (Poyner et al., 2002; Hay et al., 2015).”
BackgroundSelf-citationAdrenomedullin, a Multifunctional Regulatory Peptide*
Hinson, J. P., Kapas, S., & Smith, D. M. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0396 · Cited by 752
Amara, S. G., Arriza, J. L., Leff, S. E., Swanson, L. W., Evans, R. M., & Rosenfeld, M. G. (1985) · Science · doi:10.1126/science.2994212 · Cited by 610
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: g protein-coupled receptors
Alexander, S. P., Christopoulos, A., Davenport, A. P., Kelly, E., Marrion, N. V., Peters, J. A., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13878 · Cited by 588
Christopoulos, G., Perry, K. J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., & Sexton, P. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.235 · Cited by 486
Phase-plate cryo-EM structure of a class B GPCR–G-protein complex
Liang, Y.-L., Khoshouei, M., Radjainia, M., Zhang, Y., Glukhova, A., Tarrasch, J., Thal, D. M., Furness, S. G. B., Christopoulos, G., Coudrat, T., et al. (2017) · Nature · doi:10.1038/nature22327 · Cited by 462
Roh, J., Chang, C. L., Bhalla, A., Klein, C., & Hsu, S. Y. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305332200 · Cited by 443
Amylin: Pharmacology, Physiology, and Clinical Potential
Hay, D. L., Chen, S., Lutz, T. A., Parkes, D. G., & Roth, J. D. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010629 · Cited by 400
Self-citationMuff, R., Bühlmann, N., Fischer, J. A., & Born, W. (1999) · Endocrinology · doi:10.1210/endo.140.6.6930 · Cited by 273
Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator
Takei, Y., Inoue, K., Ogoshi, M., Kawahara, T., Bannai, H., & Miyano, S. (2004) · FEBS Letters · doi:10.1016/s0014-5793(03)01368-1 · Cited by 268
Adrenomedullin, a Multifunctional Regulatory Peptide
Hinson, J. P. (2000) · Endocrine Reviews · doi:10.1210/er.21.2.138 · Cited by 256
Keller, J., Catala-Lehnen, P., Huebner, A. K., Jeschke, A., Heckt, T., Lueth, A., Krause, M., Koehne, T., Albers, J., Schulze, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms6215 · Cited by 211
Pharmacological Discrimination of Calcitonin Receptor: Receptor Activity-Modifying Protein Complexes
Hay, D. L., Christopoulos, G., Christopoulos, A., Poyner, D. R., & Sexton, P. M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008615 · Cited by 210
Self-citationShi, L., Lehto, S. G., Zhu, D. X. D., Sun, H., Zhang, J., Smith, B. P., Immke, D. C., Wild, K. D., & Xu, C. (2016) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.227793 · Cited by 208
Crystal structure of the GLP-1 receptor bound to a peptide agonist
Jazayeri, A., Rappas, M., Brown, A. J. H., Kean, J., Errey, J. C., Robertson, N. J., Fiez-Vandal, C., Andrews, S. P., Congreve, M., Bortolato, A., et al. (2017) · Nature · doi:10.1038/nature22800 · Cited by 197
Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles
Hay, D. L., & Pioszak, A. A. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103120 · Cited by 190
Self-citationA second trigeminal CGRP receptor: function and expression of the AMY 1 receptor
Walker, C. S., Eftekhari, S., Bower, R. L., Wilderman, A., Insel, P. A., Edvinsson, L., Waldvogel, H. J., Jamaluddin, M. A., Russo, A. F., & Hay, D. L. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.197 · Cited by 189
Self-citationter Haar, E., Koth, C. M., Abdul-Manan, N., Swenson, L., Coll, J. T., Lippke, J. A., Lepre, C. A., Garcia-Guzman, M., & Moore, J. M. (2010) · Structure · doi:10.1016/j.str.2010.05.014 · Cited by 189
Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission
Yarwood, R. E., Imlach, W. L., Lieu, T., Veldhuis, N. A., Jensen, D. D., Klein Herenbrink, C., Aurelio, L., Cai, Z., Christie, M. J., Poole, D. P., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706656114 · Cited by 185
Regulation of signal transduction by calcitonin gene-related peptide receptors
Walker, C. S., Conner, A. C., Poyner, D. R., & Hay, D. L. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.06.006 · Cited by 166
Self-citationTilakaratne, N., Christopoulos, G., Zumpe, E. T., Foord, S. M., & Sexton, P. M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39040-8 · Cited by 165
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Tso, A. R., & Goadsby, P. J. (2017) · Current Treatment Options in Neurology · doi:10.1007/s11940-017-0463-4 · Cited by 161
Mason, B. N., Kaiser, E. A., Kuburas, A., Loomis, M.-C. M., Latham, J. A., Garcia-Martinez, L. F., & Russo, A. F. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2967-16.2016 · Cited by 158
The pharmacology of Adrenomedullin 2/Intermedin
Hong, Y., Hay, D. L., Quirion, R., & Poyner, D. R. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01530.x · Cited by 144
Self-citationLigand-Dependent Modulation of G Protein Conformation Alters Drug Efficacy
Furness, S. G. B., Liang, Y.-L., Nowell, C. J., Halls, M. L., Wookey, P. J., Dal Maso, E., Inoue, A., Christopoulos, A., Wootten, D., & Sexton, P. M. (2016) · Cell · doi:10.1016/j.cell.2016.09.021 · Cited by 134
Bomberger, J. M., Parameswaran, N., Hall, C. S., Aiyar, N. V., & Spielman, W. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m413786200 · Cited by 125
Booe, J. M., Walker, C. S., Barwell, J., Kuteyi, G., Simms, J., Jamaluddin, M. A., Warner, M. L., Bill, R. M., Harris, P. W., Brimble, M. A., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.04.018 · Cited by 122
Self-citationHay, D. L., & Walker, C. S. (2017) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13064 · Cited by 119
Self-citationOliver, K. R., Kane, S. A., Salvatore, C., Mallee, J. J., Kinsey, A. M., Koblan, K. S., Keyvan‐Fouladi, N., HEAVENS, R. P., Wainwright, A., Jacobson, M. A., et al. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01688.x · Cited by 118
Mack, C. M., Soares, C. J., Wilson, J., Athanacio, J., Turek, V. F., Trevaskis, J. L., Roth, J. D., Smith, P. A., Gedulin, B. R., Jodka, C. M., et al. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.238 · Cited by 113
Cottrell, G. S., Roosterman, D., Marvizón, J. C. G., Song, B., Wick, E., Pikios, S., Wong, H. C., Berthelier, C., Tang, Y. T., Sternini, C., et al. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20669 · Cited by 109
Bailey, R., Walker, C. S., Ferner, A. H., Loomes, K., Prijic, G., Halim, A., Whiting, L., Phillips, A., & Hay, D. L. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01717.x · Cited by 107
Self-citationBower, R. L., & Hay, D. L. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13496 · Cited by 104 · cited 4×
“…two peptides, the first residues N-terminal to the disulphide bond do not appear to be necessary for biological activity, and the AM and AM2/IMD peptides can be considered as functional ~40 amino acid peptides (Bailey and Hay, 2006; Hong et al., 2012; Watkins et al., 2013; Bower and Hay, 2016).”
BackgroundInfluentialSelf-citationMoore, E. E., Kuestner, R. E., Stroop, S. D., Grant, F. J., Matthewes, S. L., Brady, C. L., Sexton, P. M., & Findlay, D. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.8.7476993 · Cited by 104
Binding of Filamin to the C-terminal Tail of the Calcitonin Receptor Controls Recycling
Seck, T. L., Baron, R., & Horne, W. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209655200 · Cited by 103
Pharmacology of the human CGRP1 receptor in Cos 7 cells
Bailey, R. J., & Hay, D. L. (2005) · Peptides · doi:10.1016/j.peptides.2005.11.014 · Cited by 102
Self-citationTargeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine
Moore, E. L., & Salvatore, C. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01633.x · Cited by 99
Weston, C., Winfield, I., Harris, M., Hodgson, R., Shah, A., Dowell, S. J., Mobarec, J. C., Woodlock, D. A., Reynolds, C. A., Poyner, D. R., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.751362 · Cited by 95
Self-citationCalcitonin Receptor-stimulating Peptide, a New Member of the Calcitonin Gene-related Peptide Family
Katafuchi, T., Kikumoto, K., Hamano, K., Kangawa, K., Matsuo, H., & Minamino, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207970200 · Cited by 95
Hay, D. L., Christopoulos, G., Christopoulos, A., & Sexton, P. M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027953 · Cited by 90
Self-citationProlonged Calcitonin Receptor Signaling by Salmon, but Not Human Calcitonin, Reveals Ligand Bias
Andreassen, K. V., Hjuler, S. T., Furness, S. G., Sexton, P. M., Christopoulos, A., Nosjean, O., Karsdal, M. A., & Henriksen, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092042 · Cited by 89
Hay, D. L., Poyner, D. R., & Quirion, R. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00372 · Cited by 86
Self-citationAmylin receptors mediate the anorectic action of salmon calcitonin (sCT)
Lutz, T. A., Tschudy, S., Rushing, P. A., & Scharrer, E. (2000) · Peptides · doi:10.1016/s0196-9781(99)00208-9 · Cited by 85
Poyner, D. R., Andrew, D. P., Brown, D., Bose, C., & Hanley, M. R. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14272.x · Cited by 81
Self-citationAdrenomedullin Promotes Proliferation and Migration of Cultured Endothelial Cells
Miyashita, K., Itoh, H., Sawada, N., Fukunaga, Y., Sone, M., Yamahara, K., Yurugi, T., & Nakao, K. (2003) · Hypertension Research · doi:10.1291/hypres.26.s93 · Cited by 81
CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured
Walker, C. S., Raddant, A. C., Woolley, M. J., Russo, A. F., & Hay, D. L. (2017) · Cephalalgia · doi:10.1177/0333102417691762 · Cited by 81
Self-citationBomberger, J. M., Spielman, W. S., Hall, C. S., Weinman, E. J., & Parameswaran, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501751200 · Cited by 78
Calcitonin and Amylin Receptor Peptide Interaction Mechanisms
Lee, S. M., Hay, D. L., & Pioszak, A. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.713628 · Cited by 78
Self-citationChoksi, T., Hay, D. L., Legon, S., Poyner, D. R., Hagner, S., Bloom, S. R., & Smith, D. M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704761 · Cited by 76
Self-citationChen, W.-J., Armour, S. L., Way, J. M., Chen, G., Watson, C., Irving, P. E., Cobb, J. E., Kadwell, S. H., Beaumont, K. C., Rimele, T., et al. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.6.1164 · Cited by 74
Miller, S., Liu, H., Warfvinge, K., Shi, L., Dovlatyan, M., Xu, C., & Edvinsson, L. I. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.04.046 · Cited by 73
Andreassen, K. V., Feigh, M., Hjuler, S. T., Gydesen, S., Henriksen, J. E., Beck‐Nielsen, H., Christiansen, C., Karsdal, M. A., & Henriksen, K. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00121.2014 · Cited by 72
Does salmon calcitonin cause cancer? A review and meta-analysis
Wells, G. A., Chernoff, J., Gilligan, J. P., & Krause, D. S. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3339-z · Cited by 71
Adrenomedullin induces lymphangiogenesis and ameliorates secondary lymphoedema
Jin, D., Harada, K., Ohnishi, S., Yamahara, K., Kangawa, K., & Nagaya, N. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn228 · Cited by 68
Structure–activity relationships for α‐calcitonin gene‐related peptide
Watkins, H. A., Rathbone, D. L., Barwell, J., Hay, D. L., & Poyner, D. R. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12072 · Cited by 66
Self-citationLeuthäuser, K., Gujer, R., Aldecoa, A., McKinney, R. A., Muff, R., Fischer, J. A., & Born, W. (2000) · Biochemical Journal · doi:10.1042/bj3510347 · Cited by 66
Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases
Zhang, S., Xu, M., & Wang, X. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13814 · Cited by 66
Rist, B., Entzeroth, M., & Beck‐Sickinger, A. G. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970533r · Cited by 65
The acute effect of amylin and salmon calcitonin on energy expenditure.
Wielinga, P., Alder, B., & Lutz, T. (2007) · Physiology and Behavior · doi:10.1016/j.physbeh.2007.02.012 · Cited by 64
Nilsson, C., Hansen, T. K., Rosenquist, C., Hartmann, B., Kodra, J. T., Lau, J. F., Clausen, T. R., Raun, K., & Sams, A. G. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.01.003 · Cited by 64
Gydesen, S., Hjuler, S. T., Freving, Z., Andreassen, K. V., Sonne, N., Hellgren, L. I., Karsdal, M. A., & Henriksen, K. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13723 · Cited by 64
Hou, M., Xing, H., Cai, Y., Li, B., Wang, X., Pan, L., Hu, X., & Chen, J. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-017-0750-1 · Cited by 64
Analysis of the cellular expression pattern of β‐CGRP in α‐CGRP‐deficient mice
Schütz, B., Mauer, D., Salmon, A., Changeux, J., & Zimmer, A. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20211 · Cited by 63
Gydesen, S., Andreassen, K. V., Hjuler, S. T., Christensen, J. M., Karsdal, M. A., & Henriksen, K. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00514.2015 · Cited by 58
Nikitenko, L. L., Blucher, N., Fox, S. B., Bicknell, R., Smith, D. M., & REES, M. C. P. (2006) · Journal of Cell Science · doi:10.1242/jcs.02783 · Cited by 57
Hay, D. L., Howitt, S. G., Conner, A. C., Doods, H. N., Schindler, M., & Poyner, D. R. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704844 · Cited by 57
Self-citationFindlay, D. M., & Sexton, P. M. (2004) · Growth Factors · doi:10.1080/08977190410001728033 · Cited by 54
Eiden, S., Daniel, C., Steinbrück, A., Schmidt, I., & Simon, E. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.018671 · Cited by 54
Pharmacology of SB-273779, a Nonpeptide Calcitonin Gene-Related Peptide 1 Receptor Antagonist
Aiyar, N. V., Daines, R. A., Disa, J., Chambers, P. A., Sauermelch, C. F., Quiniou, M.-J., Khandoudi, N., Gout, B., Douglas, S. A., & Willette, R. N. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38815-9 · Cited by 51
Salvatore, C., Mallee, J. J., Bell, I. M., et al. (2006) · Biochemistry · doi:10.1021/bi052044w · Cited by 50
Ontogeny of calcitonin receptor mRNA and protein in the developing central nervous system of the rat
Tolcos, M., Tikellis, C., Rees, S. M., Cooper, M. E., & Wookey, P. J. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10478 · Cited by 49
CGRP Mechanism Antagonists and Migraine Management
Karsan, N., & Goadsby, P. J. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0547-z · Cited by 48
Taylor, M. M., Bagley, S. L., & Samson, W. K. (2005) · Endocrinology · doi:10.1210/en.2005-0949 · Cited by 47
Type II Turn of Receptor-bound Salmon Calcitonin Revealed by X-ray Crystallography
Johansson, E., Hansen, J. L., Hansen, A. M. K., Shaw, A. C., Becker, P. B., Schäffer, L., & Reedtz‐Runge, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.726034 · Cited by 44
Tomabechi, Y., Krippner, G. Y., Rendle, P. M., Squire, M. A., & Fairbanks, A. J. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201303303 · Cited by 41
Watkins, H. A., Chakravarthy, M., Abhayawardana, R. S., Gingell, J. J., Garelja, M. L., Pardamwar, M., Mcelhinney, J., Lathbridge, A., Constantine, A., Harris, P. W. R., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.688218 · Cited by 41
Self-citationKowalczyk, R., Brimble, M. A., Tomabechi, Y., Fairbanks, A. J., Fletcher, M. M., & Hay, D. L. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob01208a · Cited by 40
Self-citationKatafuchi, T., Yasue, H., Osaki, T., & Minamino, N. (2009) · Peptides · doi:10.1016/j.peptides.2009.06.012 · Cited by 37
Muff, R., Stangl, D., Born, W., & Fischer, J. A. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb22760.x · Cited by 34
Robinson, S. D., Aitken, J. F., Bailey, R. J., Poyner, D. R., & Hay, D. L. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.156448 · Cited by 34
Self-citationGydesen, S., Andreassen, K. V., Hjuler, S. T., Hellgren, L. I., Karsdal, M. A., & Henriksen, K. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00419.2016 · Cited by 34
Zimmermann, U., Flühmann, B., Born, W., Fischer, J., & Muff, R. (1997) · Journal of Endocrinology · doi:10.1677/joe.0.1550423 · Cited by 32
Hashimoto, H., Hyodo, S., Kawasaki, M., Shibata, M., Saito, T., Suzuki, H., Otsubo, H., Yokoyama, T., Fujihara, H., Higuchi, T., et al. (2007) · Peptides · doi:10.1016/j.peptides.2007.02.007 · Cited by 28
Analysis of the proteolysis of bioactive peptides using a peptidomics approach
Kim, Y., Lone, A. M., & Saghatelian, A. (2013) · Nature Protocols · doi:10.1038/nprot.2013.104 · Cited by 28
Harikumar, K. G., Ball, A. M., Sexton, P. M., & Miller, L. J. (2010) · Regulatory Peptides · doi:10.1016/j.regpep.2010.06.001 · Cited by 28
Takei, Y., Hashimoto, H., Inoue, K., Osaki, T., Yoshizawa‐Kumagaye, K., Tsunemi, M., Watanabe, T. X., Ogoshi, M., Minamino, N., & Ueta, Y. (2008) · Journal of Endocrinology · doi:10.1677/joe-07-0541 · Cited by 26
Adrenomedullin 2.0: Adjusting Key Levers for Metabolic Stability
Schönauer, R. A.-R., Els‐Heindl, S., Fischer, J., Köbberling, J., Riedl, B., & Beck‐Sickinger, A. G. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00126 · Cited by 26
Katafuchi, T., & Minamino, N. (2004) · Peptides · doi:10.1016/j.peptides.2004.08.013 · Cited by 24
Sheykhzade, M., Amandi, N., Pla, M. V., Abdolalizadeh, B., Sams, A. G., Warfvinge, K., Edvinsson, L. I., & Pickering, D. S. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2017.02.001 · Cited by 24
Katafuchi, T., Hamano, K., & Minamino, N. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.114 · Cited by 23
Dong, M., Cox, R. F., & Miller, L. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.011924 · Cited by 23
Takhshid, M. A., Poyner, D. R., Chabot, J., Fournier, A., Ma, W., Zheng, W., Owji, A. A., & Quirion, R. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706750 · Cited by 22
Self-citationMonoconjugation of Human Amylin with Methylpolyethyleneglycol
Sisnande, T., Guerreiro, L. H., Braga, R. R., Jotha-Mattos, L., Erthal, L. C. S., Tinoco, P., Ferreira, B. M., & Lima, L. M. T. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138803 · Cited by 21
Feigh, M., Hjuler, S. T., Andreassen, K. V., Gydesen, S., Ottosen, I., Henriksen, J. E., Beck‐Nielsen, H., Christiansen, C., Karsdal, M. A., & Henriksen, K. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.05.016 · Cited by 18
Endosomal proteolysis regulates calcitonin gene‐related peptide responses in mesenteric arteries
McNeish, A. J., Roux, B. T., Aylett, S., MaassenVanDenBrink, A., & Cottrell, G. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02129.x · Cited by 17
Udawela, M., Christopoulos, G., Morfis, M. M., Tilakaratne, N., Christopoulos, A., & Sexton, P. M. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2007.08.003 · Cited by 17
Owji, A. A., Chabot, J., Dumont, Y., & Quirion, R. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9062-x · Cited by 15
Synthesis and amylin receptor activity of glycomimetics of pramlintide using click chemistry
Yule, L. R., Bower, R. L., Kaur, H., Kowalczyk, R., Hay, D. L., & Brimble, M. A. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob00850j · Cited by 15
Self-citationGennari, C., & Agnusdei, D. (1994) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1994.tb09806.x · Cited by 13
Amylin(1–8) is Devoid of Anabolic Activity in Bone
Ellegaard, M., Thorkildsen, C., Petersen, S., Petersen, J. S., Jørgensen, N. R., Just, R., Schwarz, P., Ramírez, M. T., & Stahlhut, M. (2010) · Calcified Tissue International · doi:10.1007/s00223-010-9338-3 · Cited by 12
Kuwasako, K., Sekiguchi, T., Nagata, S., Jiang, D., Hayashi, H., Murakami, M., Hattori, Y., Kitamura, K., & Kato, J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.138 · Cited by 10
The role of glutamic acid 73 in adrenomedullin interactions with rodent AM2 receptors
Halim, A., & Hay, D. L. (2012) · Peptides · doi:10.1016/j.peptides.2012.04.011 · Cited by 6
Self-citationKuwasako, K., Kitamura, K., Nagata, S., Nozaki, N., & Kato, J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.037 · Cited by 5
β-arrestins negatively control human adrenomedullin type 1-receptor internalization
Kuwasako, K., Kitamura, K., Nagata, S., Sekiguchi, T., Jiang, D., Murakami, M., Hattori, Y., & Kato, J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.04.083 · Cited by 3
Cited by
G protein-coupled receptors: structure- and function-based drug discovery
Yang, D., Zhou, Q., Labroska, V., Qin, S., Darbalaei, S., Wu, Y., Yuliantie, E., Xie, L., Tao, H., Cheng, J., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00435-w · Cited by 632
CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond
Russo, A. F., & Hay, D. L. (2023) · Physiological Reviews · doi:10.1152/physrev.00059.2021 · Cited by 382
Self-citationMigraine: disease characterisation, biomarkers, and precision medicine
Ashina, M., Terwindt, G. M., Al-Karagholi, M. A.-M., de Boer, I., Lee, M. J., Hay, D. L., Schulte, L. H., Hadjikhani, N., Sinclair, A. J., Ashina, H., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32162-0 · Cited by 381
Self-citationLong-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?
Tak, Y. J., & Lee, S. Y. (2021) · Current Obesity Reports · doi:10.1007/s13679-020-00422-w · Cited by 343
Biased Receptor Signaling in Drug Discovery
Kenakin, T. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.016790 · Cited by 294
Metadata
- Authors
- Hay, D. L., Garelja, M. L., Poyner, D. R., & Walker, C. S.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2017-11-28
- Volume
- 175
- Issue
- 1
- Pages
- 3-17
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2765091532
- Cited by
- 370
- References
- 107
- FWCI
- 14.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.